Cargando…

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer

Breast cancer is the most prevalent malignancy in women. The success of breast cancer treatment relies on the ability to detect the disease and correct molecular abnormalities at an early stage of disease development. A recent article describes a marked decrease in the levels of ferroportin in breas...

Descripción completa

Detalles Bibliográficos
Autor principal: Pogribny, Igor P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096960/
https://www.ncbi.nlm.nih.gov/pubmed/21062518
http://dx.doi.org/10.1186/bcr2641